February 14, 2025
ATA Action Letter to DEA on Expansion of Buprenorphine Treatment via Telemedicine Encounter Final Rule
ATA Action Letter to DEA
ATA Action submitted comments in response to the DEA’s Expansion of Buprenorphine Treatment via Telemedicine Encounter Final Rule.